Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. is projected to experience a robust annual normalized funds from operations per share (FFOps) growth of 7.9% over the next five years, showcasing its strong financial trajectory. The company anticipates an increase in rental income following upcoming lease expirations, particularly in the skilled nursing segment, which could serve as a catalyst for further revenue growth. Additionally, despite some short-term fluctuations in the SHOP segment, the organization benefits from solid fundamentals and a promising pipeline of accretive investment opportunities.

Bears say

National Health Investors Inc is facing potential underperformance risks primarily due to the possibility of a lower-than-expected rent reset from the NHC, which could negatively impact rental revenue. Additionally, there are concerns regarding deferred rent collections and the financial stability of operators, especially in light of potential future pandemic-related challenges. The company has adjusted its 2026 funds from operations (FFO) estimate downward to $5.00 per share, indicating a more conservative outlook on net investments, and it remains below consensus expectations, suggesting overall weakness in financial performance projections.

NHI has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 4 analysts, NHI has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $88.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $88.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.